Bingqing Yang
Beijing, 100015, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Single-nucleus and spatial transcriptomic analyses reveal intra-tissue heterogeneity of PNPLA3.
Journal: Journal of hepatology
Published: March 31, 2026
Hepatic CTSB is Kupffer cell-enriched, whereas disease-state stratification is more strongly captured by endotoxin/TLR4 programmes.
Journal: Journal of hepatology
Published: March 01, 2026
Hepatocyte CD146 and soluble CD146 promote hepatic stellate cell activation via the integrin αvβ1-p38 MAPK signaling axis to drive liver fibrosis.
Journal: Cellular and molecular life sciences : CMLS
Published: December 28, 2025
GSTM3 Knockdown Promotes Liver Fibrosis Reversal by Inhibiting Hepatic Stellate Cell Activation via PPARγ Signaling.
Journal: Journal of clinical and translational hepatology
Published: December 03, 2025
Clinicopathological features of hepatobiliary cells in primary biliary cholangitis patients with incomplete response to ursodeoxycholic acid.
Journal: BMC gastroenterology
Published: May 28, 2025
Targeting Insulin Resistance and Liver Fibrosis: CKD Screening Priorities in MASLD.
Journal: Biomedicines
Published: February 23, 2025
CKM: A new approach to managing metabolic comorbidities in MASLD?
Journal: Journal of hepatology
Published: November 26, 2024
Patients with chronic hepatitis B exhibiting significant inflammation and fibrosis should pay particular attention to the status of hepatic steatosis during antiviral therapy.
Journal: Virology journal
Published: October 03, 2024
Artemether Ameliorates Non-Alcoholic Steatohepatitis by Restraining Cross-Talk Between Lipotoxicity-Induced Hepatic Hepatocytes and Macrophages.
Journal: Phytotherapy research : PTR
Published: July 02, 2024
Showing 1-10 of 10
Last Updated: 09/26/2026